Off the back of US approval of Leqembi, we have expert Dr Bill Brooks available to discuss Alzheimer's disease.
Dr Brooks has studied Alzheimer's Disease throughout his career and can comment on how the drug aims to work, what the evidence so far shows and also generally about Alzehimer's disease and its progression.
Nadia Razzhigaeva
Senior Communications & PR Officer
0452 140 477
This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…
Palliative Care Australia (PCA)has welcomednewlinkeddatareleased thisweekfrom the Australian Institute of Health and Welfare (AIHW), providing a national picture ofolder people’s access to specialist palliative…
Funding from Baszucki Group fuels program for healthcare professionals to learn by doing. SAN MATEO, Calif.–BUSINESS WIRE– Baszucki Group today announced a partnership with…
Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.
